Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Tadalafil and Finasteride may help treat aggressive melanoma.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Scalp microinfusion is a new method for treating hair loss that shows promise but needs more research for standardization.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Researchers developed a new method to test hair growth drugs and found that adult cells are best for hair growth, but the method needs improvement as it didn't create mature hair follicles.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

The model and estimator can predict drug exposure in kidney transplant patients well.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The microemulsion delivered the dye deeper into the skin than the cream.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Taking Dutasteride with Ketoconazole can increase Dutasteride's effects and side effects.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

AGA might indicate higher risk for severe COVID-19.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.